Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Revenue: 2013-2024

Historic Revenue for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $1.0 million.

  • vTv Therapeutics' Revenue was N/A to -$5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 1068.97% up from last year.
  • As of FY2024, vTv Therapeutics' Revenue stood at $1.0 million, which was up 1,068.97% from $87,000 recorded in FY2023.
  • In the past 5 years, vTv Therapeutics' Revenue registered a high of $6.4 million during FY2020, and its lowest value of $87,000 during FY2023.
  • Over the past 3 years, vTv Therapeutics' median Revenue value was $1.0 million (recorded in 2024), while the average stood at $1.0 million.
  • In the last 5 years, vTv Therapeutics' Revenue slumped by 95.69% in 2023 and then skyrocketed by 1,068.97% in 2024.
  • Yearly analysis of 5 years shows vTv Therapeutics' Revenue stood at $6.4 million in 2020, then plummeted by 37.56% to $4.0 million in 2021, then crashed by 49.61% to $2.0 million in 2022, then slumped by 95.69% to $87,000 in 2023, then soared by 1,068.97% to $1.0 million in 2024.